| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |